ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 999,29
0,52%
Dow Jones
38 827,01
0,39%
DAX
18 136,73
0,79%
Brent Oil
83,165
0,05%
Bitcoin
63 724,39
-0,42%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Summit Therapeutics Inc (SMMT)

  7. Summit Therapeutics Inc (SMMT) Actualités

SMMT Summit Therapeutics Inc

4,43
0,04 (0,91%)
Avant marché
Dernière mise à jour : 14:41:56
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Summit Therapeutics Inc SMMT NASDAQ Certificat de dépôt
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,04 0,91% 4,43 14:41:56
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
4,39
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
01/5/202413:00BWSummit Therapeutics Reports Financial Results and..
24/4/202422:30BWSummit Therapeutics to Host First Quarter 2024 Financial..
11/4/202422:30BWSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned..
10/4/202413:00BWSummit Therapeutics to Present at the Stifel 2024 Targeted..
22/3/202412:00BWPromising Intracranial Anti-Tumor Activity and Safety Data..
14/3/202412:00BWIntracranial Anti-Tumor Activity and Safety of Ivonescimab..
05/3/202422:05EDGAR2Form 8-K - Current report
05/3/202413:00BWSummit Therapeutics to Present at the Barclays 26th Annual..
20/2/202414:05EDGAR2Form 8-K - Current report
20/2/202413:55EDGAR2Form S-3 - Registration statement under Securities Act of..
20/2/202413:32EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20/2/202413:00BWSummit Therapeutics Reports Financial Results and..
15/2/202423:25EDGAR2Form 8-K - Current report
14/2/202422:35EDGAR2Form 5 - Annual statement of changes in beneficial ownership..
14/2/202416:29BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023..
14/2/202413:00BWSummit Therapeutics to Host Fourth Quarter & Full Year 2023
07/2/202413:00BWSummit Therapeutics to Present at Oppenheimer’s 34th Annual..
08/1/202415:07EDGAR2Form 8-K - Current report
08/1/202415:00BWSummit Therapeutics Announces Updated Phase II Data for..
04/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/1/202422:06EDGAR2Form 8-K - Current report
03/1/202413:30BWSummit Therapeutics to Present at the 42nd Annual J.P...
13/12/202322:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/11/202314:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202314:03EDGAR2Form 8-K - Current report
07/11/202313:00BWSummit Therapeutics Reports Financial Results and..
02/11/202321:41BWLaura Chow, MD, Cancer Immunotherapy Trailblazer, Joins..
31/10/202321:02EDGAR2Form 8-K - Current report
31/10/202313:00BWIvonescimab’s Novel Mechanism of Action Highlighting..
26/10/202314:00BWSummit Therapeutics to Host Q3 2023 Financial Results &..
19/10/202314:00BWH. Jack West, MD, Renowned Oncologist & Lung Cancer Expert,..
16/10/202313:46EDGAR2Form 8-K - Current report
16/10/202313:00BWSummit Therapeutics Appoints Proven Biotech Leader Manmeet..
19/9/202321:40EDGAR2Form DEF 14A - Other definitive proxy statements
08/9/202322:08EDGAR2Form PRE 14A - Other preliminary proxy statements
09/8/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:03EDGAR2Form 8-K - Current report
09/8/202313:00BWSummit Therapeutics Reports Financial Results and..
02/8/202322:05EDGAR2Form 8-K - Current report
02/8/202314:00BWSummit Therapeutics to Host Q2 2023 Financial Results &..
04/6/202314:00BWPromising Data for Investigational Innovative Bispecific..
01/6/202313:30BWIvonescimab Updated Data to be Featured at ASCO 2023
11/5/202313:30BWSummit Therapeutics Reports Financial Results and..
09/5/202313:30BWSummit Therapeutics Announces First Patient Treated in Phase..

Dernières Valeurs Consultées

NASDAQ
SMMT
Summit Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés